Heartflow, Inc.·4

Jun 18, 5:30 PM ET

Cullivan Julie A 4

4 · Heartflow, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Heartflow Director Julie Cullivan Receives 16,075-Share Award

What Happened
Julie A. Cullivan, a director of Heartflow, Inc. (HTFL), was granted a derivative equity award for 16,075 shares with a price of $32.05 per share, representing a total grant value of $515,204. This was an award/grant transaction (derivative), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-06-16; filing date: 2026-06-18 (timely filed within Form 4 rules).
  • Instrument: derivative equity award at $32.05 per share; reported total value $515,204.
  • Shares reported in grant: 16,075.
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Footnote: The award vests in full on the earlier of the day before Heartflow's 2027 annual meeting and the first anniversary of the grant date, subject to continued service.
  • Transaction code: A (award/grant).

Context
This filing reports a grant of an equity-based derivative (e.g., option or similar award) to a board member; the award is subject to vesting and was not exercised or sold. Such grants are common as director compensation and align long-term incentives with shareholders but are not the same signal as an insider buying shares in the open market.

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Award

    Stock Option

    [F1]
    2026-06-16$32.05/sh+16,075$515,20416,075 total
    Exercise: $32.05Exp: 2036-06-16Common Stock (16,075 underlying)
Footnotes (1)
  • [F1]The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.
Signature
/s/ Nga Van, by power of attorney|2026-06-18

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT